Publication | Closed Access
Long‐term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the <scp>SOPRAN</scp> and <scp>LOTUS</scp> studies
139
Citations
25
References
2015
Year
No major safety concerns arose during 5-12 years of continuous PPI therapy. (ClinicalTrials.gov: NCT00251927 and NCT00256737).
| Year | Citations | |
|---|---|---|
Page 1
Page 1